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Modifications of standard dot-blot immunoassay 
techniques have been made for the quantitation of inte- 
gral membrane protein antigens. The modification in- 
volves the signal development step, which is performed 
by using punched-out wells of the solid support (nitro- 
cellulose) to yield a soluble colored reaction product. 
This approach avoids the inhomogeneity of an insoluble 
reaction product and the subsequent quantitation prob- 
lems encountered when such product is scanned by den- 
sitometry. The method was validated by comparing the 
purification and overall recoveries of a known plasma 
membrane enzymatic marker with integral membrane 
antigens of defined localization during subcellular frac- 
tionation of mouse pancreas. The final plasma mem- 
brane fraction contained both basolateral (-20-fold 
enriched) and apical membrane (---fold enriched) do- 
mains. 0 lB91 Academic Press, Inc. 
A large number of immunoassays exist that are based 
on a variety of methodologies [for review see (l-4)]. 
Many assays have been developed for quantitation of 
specific soluble molecules of interest, but only a few as- 
says have been designed to provide systems useful for 
quantitation of membrane antigens (56). These assays 
have not been sufficiently characterized for reliable 
quantitation of membrane antigens in different subcel- 
lular fractions. The objective of the work reported here 
was to develop an immunoassay for quantitation of in- 
tegral membrane antigens in complex mixtures during 
subcellular fractionation. The assay is currently being 
used to develop methods to subfractionate pancreatic 
acinar cell plasma membranes into apical and basolat- 
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era1 fractions. A variation of the assay is also being used 
to screen for hybridomas producing monoclonal anti- 
bodies to membrane antigens. 
MATERIALS AND METHODS 
Reagents. Sheep anti-rat Ig-@-galactosidase was ob- 
tained from Amersham (Naperville, IL). Nitrocellulose 
paper (0.45-pm pore size) was obtained from Bio-Rad 
(Richmond, CA). All other chemicals were obtained 
from Sigma Chemical (St. Louis, MO). 
Subcellular fractionation of mouse pancreas. Plasma 
membranes were prepared from mouse pancreas using 
an adaptation of an established technique (7,8). All 
steps were performed at 4°C. Mouse pancreatic tissue 
was minced with scissors and suspended in 1 mM 
NaHCO,, pH 7.4,0.5 mM MgCl,, 0.1 mM phenylmethyl- 
sulfonyl fluoride, and 1 mM benzamidine at 1 g tissue/5 
ml buffer. The suspension was homogenized for 30 s at 
setting 5 with a Brinkman homogenizer (Brinkman In- 
struments, Westbury, NY), followed by three strokes 
with a glass-Teflon homogenizer at 1300 rpm. The ho- 
mogenate was centrifuged to pellet unbroken cells by 
accelerating the centrifuge to 1300g and then stopping 
immediately. The pellet was rehomogenized and pel- 
leted as above and the two supernatants were combined. 
The combined supernatants were considered as the ho- 
mogenate which was then diluted 20-fold in the same 
buffer without MgCl, and plus 0.7 mM EDTA, and incu- 
bated on ice for 10 min. The homogenate was filtered 
through four layers of gauze and was centrifuged at 
1300g for 15 min to pellet large membrane sheets. The 
upper surface of this pellet (the “fluffy” layer) was 
rinsed off with homogenization buffer and the remain- 
ing pellet was considered as the crude plasma mem- 
brane fraction. The crude plasma membranes were re- 
suspended in 46% sucrose (w/v) in a Dounce 
homogenizer with a tight pestle (pestle A), placed into 
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SW 41 centrifuge tubes, overlaid with 10% sucrose, and 
centrifuged for 2 h at 38,000 rpm. The purified plasma 
membranes were removed from the interface, washed in 
phosphate-buffered saline (PBS;’ 20 mM PO,, 150 mM 
NaCl, pH 7.4) by ultracentrifugation, resuspended in 
PBS at -1 mg protein per ml, and stored at -70°C. 
h4onoclonaZ antibodies. The monoclonal antibodies 
used were produced by fusion of the mouse myeloma 
SP2/0-Ag14 with rat spleen cells by conventional meth- 
ods (9). Acinar-1, one of the monoclonal antibodies 
(mAb) used in this study, has been described previously 
(8) and was raised against a primary monolayer culture 
of mouse acinar cells. The other mAb used in the 
current study, 4.1B12, was obtained by immunizing rats 
with 1% Triton X-100 solubilized plasma membranes 
prepared as above. The characteristics of the mAbs are 
described under Results. 
Standard dot-blot immunoassay protocol. Samples 
for assay were suspended at 4°C in Tris-buffered saline 
(TBS; 10 mM Tris, pH 7.0, 150 mM NaCl) at protein 
concentrations of 0.1 mg/ml and disrupted by sonica- 
tion on ice with a probe-type sonicator (Branson Ultra- 
sonics Corp., Danbury, CT) for 5 s at a 60-W output. 
Serial twofold dilutions were made in TBS and applied 
to 0.45-pm pore size nitrocellulose in a commercial dot- 
blot apparatus (Bio-Rad). The apparatus was then dis- 
assembled and the nitrocellulose was placed in 10 ml of 
blocking solution (3% bovine serum albumin, 0.05% 
Tween-20, in PBS) and incubated with gentle agitation 
for 2 h at room temperature. After blocking, 10 ml of 
mAb-containing spent hybridoma culture supernatant 
(10% fetal bovine serum in RPMI-1640 medium) was 
added to the blocking solution and incubated overnight 
at 4°C with gentle agitation. The nitrocellulose was 
then washed 4 X 10 min with 25 ml of 0.05% Tween-20 
in PBS. Next, the nitrocellulose was incubated with 10 
ml of sheep anti-rat P-galactosidase-coupled second an- 
tibody diluted 1:1250 in blocking solution for 2 h at room 
temperature with agitation and then washed again as 
above. For the enzymatic readout, the individual sam- 
ples were punched out from the nitrocellulose with an 
eight-channel punch of 6 mm diameter (designed and 
built in the Physiology Department Machine Shop) and 
transferred to wells of a 96-well plate. Sample blanks 
were obtained by punching out areas of the nitrocellu- 
lose between the wells used for samples. A loo-p1 sam- 
ple of substrate solution (3 mM o-nitrophenyl galacto- 
pyranoside (oNPG), 10 mM 2-mercaptoethanol, 10 mM 
MgSO,, in PBS) was added, and the samples were incu- 
bated until sufficient color developed, usually 0.5-2 h at 
room temperature. The reaction was stopped with 50 ~1 
2 Abbreviations used: PBS, phosphate-buffered saline; TBS, Tris- 
buffered saline; oNPG, o-nitrophenyl galactopyranoside; SDS, so- 
dium dodecyl sulfate; pNPPase, p-nitrophenyl phosphatase. 
of 1 M Na,CO,, and the reaction product was trans- 
ferred to a clean 96-well plate. The OD,, nm was read 
using a multiwell plate reader (Flow Labs, McLean, 
VA), which was zeroed using the reaction product from 
sample blanks prepared as described above. 
Variation of the assay to screen for hybridomas produc- 
ing mAb against membrane proteins. A variation of the 
assay was made which allows testing of large numbers of 
hybridoma culture supernatants as a screening proce- 
dure for mAb against membrane fractions. The same 
amount of membrane protein was applied to each well 
in the dot-blot apparatus and the samples were 
punched-out and placed in 96 well plates. All the incu- 
bations were then carried out in the 96-well plates, al- 
lowing different primary mAbs to be used for each sam- 
ple. With this method, it was possible to screen -2000 
wells for membrane antigen-specific mAb production in 
a single run covering 2 days time. 
Data analysis. The immunoassay was designed to be 
a pseudo-first-order reaction (see Results) such that the 
signal would be linearly related to the amount of antigen 
in the sample. The data were analyzed by linear regres- 
sion of the OD4,,5nm vs micrograms of sample and the 
slopes of these lines were taken as the specific activities 
of the antigen in the samples. Regression coefficients 
usually exceeded 0.9. 
Immunoblots of Western-transferred protein. Plasma 
membranes were run on a 7.5% polyacrylamide-SDS 
gel with 2-mercaptoethanol followed by Western 
transfer to nitrocellulose (10). Immunoblots of Western 
transferred plasma membranes were performed as 
previously described (8) to determine antigen molecular 
masses. 
Electron microscopic immunoperoxidase labeling. A 
preembedding immunoperoxidase technique was used 
for mAb-binding localization as previously de- 
scribed (811). 
K+-stimulated pNPPase assay and protein deter- 
mination. Na+/K+-ATPase activity was measured 
as potassium-stimulated p-nitrophenyl phosphatase 
(pNPPase) activity as previously described (8) on fresh 
samples. Protein was measured on samples solubilized 
by boiling in 0.1 N NaOH using the Bradford method 
(12) with a commercial reagent (Bio-Rad). 
RESULTS AND DISCUSSION 
Characterization of the mono&ma1 antibodies. TWO 
mAbs were used for these studies. Acinar-1 has been 
described previously (8) and is a rat IgG,, that recog- 
nizes a 94-kDa protein localized by indirect immunofluo- 
rescence and electron microscopic immunoperoxidase 
labeling to the apical plasma membrane domain of a 
number of murine exocrine cell types, including the pan- 
creatic acinar cell. The other mAb, currently designated 







FIG. 1. Immunoblot of Western-transferred plasma membrane 
protein. The nitrocellulose was immunoblotted with mAb 4.1B12 (left 
lane) and mAb Acinar-1 (right lane). The molecular weight standards 
are as indicated in the figure. 
4.1B12, is also a rat IgG,, which recognizes a 32-kDa 
protein of mouse pancreatic acinar cells. A Western blot 
shown in Fig. 1 demonstrates the molecular weight de- 
termination for these antigens using isolated pancreatic 
plasma membranes. By indirect immunofluorescence 
(not shown) and electron microscopic immunoperoxi- 
dase labeling (Fig. 2), 4.1B12 labels the basal and lateral 
membrane domains of acinar cells with no detectable 
labeling of the apical membrane domain. The mem- 
brane proteins studied in this work were integral mem- 
brane proteins, as determined by the inability of 0.1 M 
Na,CO, to solubilize them (not shown). 
Design of the immunoassay. Initial attempts were 
made to use a solid-phase enzymatic immunoassay 
whose end product was an insoluble deposit on nitrocel- 
lulose paper (13,14). This approach did not work well to 
quantitate antigens in various membrane fractions. The 
major problem was uneven development of reaction 
product on the nitrocellulose which made quantitation 
FIG. 2. Electron microscopic immunoperoxidase labeling of mouse 
pancreatic tissue with mAb 4.1B12. Note that the label is restricted to 
the basal and lateral plasma membrane domains and that the apical 
plasma membrane is not labeled. Scale bar, 2.5 pm. 
by reflectance densitometry unreliable. This may have 
been due to the particulate nature of the samples (mem- 
brane sheets and vesicles) and uneven deposition on the 
nitrocellulose. Therefore, the assay was adapted to pro- 
duce a soluble end product which could be reliably 
quantitated by absorption spectrophotometry. The as- 
say was designed to obtain a pseudo-first-order rela- 
tionship between the amount of antigen applied and the 
signal observed. To achieve this, the amount of antigen 
was limiting and all other reagents were applied at satu- 
rating levels. Therefore, the form of the data assumes a 
linear relationship between antigen and signal and is 
easily analyzed by linear regression to obtain a slope, 
which gives a specific activity value for the antigen con- 
tent of the sample. 
Color development. Details of the assay are given 
under Materials and Methods. Up until the final step, 
color development, the nitrocellulose remained as a sin- 
pg Protein 
FIG. 3. Immunoassay with mAb 4.1B12 of different subcellular 
fractions obtained during plasma membrane preparation. The sam- 
ples were: homogenate (circles); supernatant (triangles); fluffy layer 
(squares); crude plasma membranes (inverted triangles); and final 
plasma membranes (diamonds). Data are means -t SD from triplicate 
determinations from a representative experiment. 
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TABLE 1 
Balance Sheet for Immunoreactivities and pNPPase Activity in Subcellular Fractions of Mouse Pancreas 
during Plasma Membrane Preparation 
Sample 
mAb 4.1B12 pNPPase” 
(basolateral) (basolateral) 
Enrichmentb % of total Enrichment % of total 
mAb Acinar-1 
(apical) 
Enrichment % of total 
Supernatant 0.60 1- 0.04 44 +- 5.2 0.47 + 0.12 34 + 6.2 1.0 -t 0.14 75 zk 5.7 
Fluffy layer 2.9 k 0.68 46+ 11 2.7 -t 0.00 44 k 0.58 1.7 + 0.21 27 k 3.0 
Crude PMd 1.9 + 0.69 8.5 + 2.2 1.8 -t 0.21 8.3 rt 2.3 1.2 + 0.25 5.6 f 0.68 
Final PM 21 f 4.5 4.4 ? 0.95 22 ?I 2.8 4.8 f 1.9 4.4 r 0.23 0.94 + 0.25 
Recovery’ 99* 15 86 + 5.6 108 f 6.1 
’ Na+/K+-ATPase activity measured as K+-stimulated pNPPase activity. 
* Values are relative to the homogenate specific activity, which was defined as unity. 
’ Values are relative to the total activity of the homogenate, which was defined as 100%. 
d The abbreviation PM stands for plasma membrane. 
e Recoveries were calculated from the sum of activities in the supernatant plus fluffy layer plus crude PM fractions as percent of total 
activity in the homogenate. All values are the means + SD from three independent preparations. 
gle piece which made all the necessary handling in the 
preceding steps easy and rapid. Now, the individual 
spots containing the samples were punched out so that 
they could be separately incubated with the chromo- 
genic substrate, oNPG, in 96-well plates. 
Linearity of the reaction. A typical assay result is 
shown in Fig. 3 using the basolateral mAb 4.1B12 and 
the different fractions obtained during membrane prep- 
aration. The signal was linearly related to the amount of 
sample up to the point where the amount of antigen is 
no longer the limiting factor. The capacity of the nitro- 
cellulose for protein binding is estimated to be 80 pg/ 
cm2 (15), which corresponds to 25 pg10.32 cm2 sample 
well, so samples of low antigen content relative to total 
protein can be assayed. The linear correlation coeffi- 
cients for the data in Fig. 3 were 0.999 for the homoge- 
nate, 0.984 for the supernatant, 0.995 for the fluffy 
layer, 0.996 for the crude plasma membrane fraction, 
and 0.998 for the final plasma membrane fraction. The 
enrichments, compared to the homogenate, of 4.1B12 
immunoreactivity (basolateral marker), K+-stimulated 
pNPPase activity (basolateral marker, [16]), and 
acinar-1 immunoreactivity (apical marker) are shown in 
Table 1. Note that the enrichments of 4.1B12 immunore- 
activity and K+-stimulated pNPPase activity parallel 
each other, as is expected since both are localized to the 
basolateral plasma membrane. The final plasma mem- 
brane fraction was enriched -2O-fold for both basolat- 
era1 markers. In addition, the final plasma membrane 
fraction was enriched about 4-fold in the apical marker, 
Acinar-1 immunoreactivity, compared to the homoge- 
nate. Thus, plasma membranes prepared as described 
contain both basolateral and apical membrane domains. 
Quantitative recovery of immunoreactivities. Other 
assays for quantitating membrane antigens have been 
described (5,6). In determining whether those assays 
were quantitative, the authors demonstrated that the 
signal obtained was proportional to the amount antigen 
in a given sample, as was carried out for the current 
assay as described above. A more rigorous test of the 
quantitative nature of an assay and its general applica- 
bility is whether overall recoveries of activities in differ- 
ent subcellular fractions are obtained. If this criterion is 
met, then the assay is of general usefulness to measure 
antigen content in various samples of complex composi- 
tion. An overall balance sheet using the different frac- 
tions obtained in preparing plasma membranes is 
shown in Table 1. The recoveries of immunoreactivities 
were near 100% for both mAbs, and a little less for the 
enzyme, which may be somewhat labile. Thus, the assay 
is quantitative using different subcellular fractions as 
well as serial dilutions of a single sample. 
Conclusions. The enzymatic dot-blot assay de- 
scribed here is a quantitative immunoassay for integral 
membrane proteins giving good overall recovery values 
for different subcellular fractions. This assay is similar 
to the enzyme-linked immunofiltration assay of IJssel- 
muiden et al. (17), except that here the color develop- 
ment step takes place in 96-well plates and does not tie 
up the filtration device. This allows a greater number of 
samples to be assayed at one time. The assay described 
here is also relatively rapid and has the capacity to han- 
dle a large number of samples. This assay does not re- 
quire pure antigen as long as relative activities and en- 
richments are sufficient. A variation of the assay allows 
the screening of large numbers of hybridomas for mem- 
brane fraction specific mAbs. 
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